Written by Heather Yoshimura, MSN, AGNP-BC Evidence-based · Peer-reviewed sources cited Last updated: March 10, 2026

You've been on birth control for years. Maybe it helped at first, or maybe it never did. But here you are, still in pain, still missing work, still wondering why nobody explains what's actually happening. You're not failing. And this isn't a compliance problem. The premise is wrong — the idea that suppressing your period will fix endometriosis. It won't. And that's because endometriosis isn't just about menstrual bleeding.

Endometriosis affects 1 in 10 women of reproductive age. It's a chronic condition driven by escaped endometrial tissue that sets off inflammation, neural infiltration (nerves growing into lesions), and central sensitization (a state where your nervous system gets stuck amplifying pain signals, even long after the initial injury) [1,2,3]. Pain in endometriosis comes from multiple overlapping mechanisms at the same time. No single medication targets all of them. That's why birth control alone leaves approximately one-third of patients in significant pain, and why rates are even worse for those with deep disease or a sensitized nervous system [1].

What birth control actually does (and doesn't do)

Combined oral contraceptives work by shutting down ovulation and reducing the amount of estrogen stimulating endometrial growth. That reduces menstrual bleeding. It can reduce period pain. But it does not eliminate the endometrial implants already growing outside your uterus. It does not reverse nerve infiltration into lesions. It does not reset your nervous system [1].

More importantly, your endometriotic tissue shows progesterone resistance. That means the tissue doesn't respond appropriately to the hormonal "off" signal birth control is trying to send [1]. You can take it perfectly and still be in pain because the mechanism that should work doesn't work in endometriosis tissue.

Stop telling yourself you're doing something wrong. You're taking the medication as prescribed. The biology of your disease is simply more complicated than a single medication can address.

Why your pain persists even on hormonal therapy

Endometriosis pain comes from at least three sources at once:

Birth control addresses only the first source by reducing menstrual bleeding. It leaves the other three untouched. That's why you might get some relief, but not complete relief. And that's why a comprehensive approach requires targeting multiple mechanisms simultaneously, not just hormonal suppression [1,4].

Why birth control sometimes doesn't work even when it should: the estrobolome

Here's something most patients never hear about. Your liver processes estrogen and tags it for elimination through your bowel. But if your gut microbiome is dysbiotic, which research shows it is in the majority of women with endometriosis, bacteria produce an enzyme called beta-glucuronidase that cuts that tag off [25,26]. The estrogen gets reabsorbed back into your bloodstream instead of leaving your body.

This recycling system is called the estrobolome: the collection of gut bacteria responsible for metabolizing estrogen. In women with endometriosis, the estrobolome is consistently dysregulated, producing more beta-glucuronidase and recycling more estrogen [26,27]. The result is a higher estrogen load in your body than your hormonal treatment is designed to suppress.

This doesn't mean birth control isn't working as designed. It means birth control is trying to reduce estrogen while another system in your body is actively recycling it back up. Your treatment is fighting a two-front battle. A comprehensive approach to endometriosis pain increasingly includes supporting gut health alongside hormonal therapy, not as an alternative to it [25,28]. Getting the gut microbiome right isn't optional if you want hormonal therapy to work better.

NSAIDs: targeting the prostaglandin fire

NSAIDs (ibuprofen, naproxen) and COX-2 selective inhibitors (celecoxib) work by blocking the enzymes that produce prostaglandins, the inflammatory molecules that drive period pain and bowel symptoms in endometriosis [4,5]. A 2017 Cochrane review confirmed NSAIDs are more effective than placebo for this type of pain [4].

For NSAIDs to work, you need continuous dosing starting 1-2 days before your period and continuing through the heavy flow days. Not taking it when the pain starts. That's a different strategy [4,12].

The catch: NSAIDs don't stop lesions from growing, and long-term use carries cardiovascular and renal risks. They're an adjunct, not a replacement for disease-modifying therapy [4].

Progestins: when birth control's not enough

If birth control isn't working, stronger progestin-only regimens often are. Unlike the low-dose progestin in many birth control pills, these are designed to suppress lesional growth more aggressively.

Dienogest 2 mg daily has the strongest evidence base of any oral progestin for endometriosis specifically. Multiple randomized trials have found it significantly reduces endometriosis pain compared to placebo and is comparable to GnRH agonists (which induce temporary medical menopause) without the bone loss [7]. Dienogest works differently than other progestins: it suppresses local aromatase activity (enzymes that produce estrogen directly in the lesions), so it hits the tissue where it lives, not just systemically [7,8].

Norethindrone acetate 5 mg daily is a well-established, lower-cost option with comparable efficacy in real-world practice [8].

Levonorgestrel-releasing IUD (Mirena) delivers progestin directly to the uterus with minimal systemic absorption. A 2022 meta-analysis of 8 randomized trials found it significantly reduced period pain in endometriosis (effect size -0.89, meaning substantial reduction) [9]. For women with heavy bleeding or who tolerate pills poorly, this is often a better choice than pills.

GnRH drugs: temporary medical menopause

GnRH agonists (leuprolide, nafarelin, goserelin) work by shutting down the pituitary, which shuts down your ovaries, which eliminates most of the estrogen in your body. For pain, they're as effective as birth control or progestins [10]. The problem: they cause bone loss, hot flashes, and mood changes. You can only use them for 6 months without damage to your skeleton unless you add back low-dose hormones (estrogen plus progestin to prevent the side effects while keeping the benefit) [10,11].

GnRH antagonists are newer and work faster without the initial flare of symptoms agonists cause. Elagolix (Orilissa) is an oral GnRH antagonist that was studied in two large clinical trials (ELARIS I and II, n=872 patients). Both low-dose and high-dose versions reduced period pain and non-menstrual pelvic pain versus placebo [12]. The high-dose version (200 mg twice daily) achieved the best results. Like agonists, you need add-back hormones after a few months to protect your bones [13].

GnRH drugs are typically reserved for when other options haven't worked, mainly because of the side effects. But if your pain is severe and refractory, they're worth discussing with your provider.

Aromatase inhibitors: the next step if standard hormones fail

Here's something most patients don't know: your endometrial lesions make their own estrogen. They express aromatase, the enzyme that produces estrogen locally, independent of your ovaries [13]. Birth control and progestins suppress ovarian estrogen, but they don't stop the lesions from making their own. This is why some women with refractory pain need an additional layer.

Aromatase inhibitors (letrozole, anastrozole) block this local estrogen production. They're typically combined with a progestin or birth control to prevent your ovaries from overcompensating and growing cysts [14]. Evidence from randomized trials shows aromatase inhibitors significantly reduce pain in women whose pain persists on standard hormonal therapy [14].

The trade-off: bone loss. If you use an aromatase inhibitor, you typically add back a bisphosphonate (a bone-protective medication) or progestin to minimize this [14]. This is a second- or third-line strategy, not first-line, but it works.

Omega-3, magnesium, and anti-inflammatory nutrition

Omega-3 supplementation (EPA and DHA) works by outcompeting arachidonic acid in your cells, reducing substrate for prostaglandin production. Large prospective studies have found higher dietary omega-3 intake was associated with a 22% lower risk of incident endometriosis [17]. Effect size is modest but clinically real. Typical dose: 1,080 mg EPA plus 720 mg DHA daily.

Magnesium glycinate helps by relaxing smooth muscle in the uterus and blocking calcium channels in muscle cells. A Cochrane review found moderate-quality evidence that magnesium is better than placebo for dysmenorrhea [18]. Typical dose: 250-360 mg elemental magnesium daily.

These are not replacements for medication, but they address inflammation from a different angle and can meaningfully reduce pain when combined with medical therapy.

Pelvic floor physical therapy: the piece almost nobody gets right

Endometriosis causes your pelvic floor muscles to tighten up. That tightness perpetuates pain independently of whether your lesions are still active [14]. Pelvic floor physical therapy — myofascial release, trigger point work, and neuromuscular re-education — addresses this muscular pain driver directly. Medications don't.

A 2023 systematic review found specialized pelvic floor PT significantly reduced dyspareunia (painful intercourse), period pain, and chronic pelvic pain in endometriosis [14]. The effect sizes ranged from moderate to large. More importantly, it works through a different mechanism than hormones: manual therapy modulates pain signal amplification in the spinal cord and brain through descending inhibitory pathways [15]. Translation: it targets a different part of the pain system.

The 2022 ESHRE guideline recommends pelvic floor PT as standard care alongside medical or surgical management [16]. If you're on medication and still in pain, pelvic floor PT is not optional. It's essential.

TENS and other neuromodulation approaches

Transcutaneous electrical nerve stimulation (TENS) applies gentle electric current to your skin to modulate pain signals in the spinal cord. A 2022 randomized trial found high-frequency TENS (80-100 Hz) applied to the lower back significantly reduced period pain (mean reduction of 2.3 points on a 10-point scale) versus sham treatment [21]. It's not a replacement for other therapies, but it's a low-risk adjunct that some patients find helpful.

Cognitive behavioral therapy and mindfulness-based stress reduction also matter. Central sensitization in endometriosis involves specific alterations in brain regions that regulate pain, and these changes respond to top-down regulatory strategies [22]. A 2023 randomized trial of pain-focused CBT in women with endometriosis showed significant reductions in pain catastrophizing and pain interference at 6 months [22].

Surgical excision: removing disease when medical management isn't enough

Laparoscopic excision by a surgeon experienced in endometriosis removes lesions and can provide durable pain relief. A 2021 Cochrane review confirmed that excision significantly reduces pain versus diagnostic laparoscopy alone [23]. Surgery works. It removes current disease.

The reality: recurrence is substantial. A 2023 cohort study documented a 10-year recurrence rate of 40-50% for endometriosis pain after surgery [24]. This means surgery removes current lesions but doesn't change the underlying biology that allowed them to grow in the first place. That's why most patients benefit from postoperative medical suppression to extend symptom-free intervals.

Surgery is not a cure. It's a reset button. It needs to be followed by comprehensive medical management to prevent disease from regrowing.

Your multimodal plan

Here's what research actually supports: simultaneous targeting of multiple mechanisms. Not sequential. Not waiting to "try birth control first." Simultaneous.

If your pain persists on birth control, your plan might include:

The architecture of your plan should match what's actually driving your pain, not a standard protocol everyone gets.

What about intimacy and sex?

Endometriosis affects sexual function in the majority of women who have it. Pain with sex (dyspareunia) is the most obvious mechanism, but there's more: reduced libido from chronic pain, side effects from medications, and the psychological toll of living with a disease that makes sex difficult [29,30]. A systematic review of sexual function in endometriosis found that sexual dysfunction extends beyond painful intercourse to include decreased satisfaction, reduced desire, and difficulty with arousal [29].

This isn't something to live with quietly. It's a quality of life outcome that deserves to be part of the treatment conversation.

Pelvic floor physical therapy specifically reduces painful intercourse. A 2023 systematic review found that specialized pelvic floor PT significantly reduced dyspareunia in women with endometriosis, with effect sizes ranging from moderate to large [14]. This is the same PT recommended for period pain and chronic pelvic pain, but the dyspareunia reduction is particularly important for sexual health outcomes.

Cognitive-behavioral therapy improves sexual satisfaction in endo patients. A randomized clinical trial of CBT in women with endometriosis found significant improvements in sexual satisfaction scores immediately after the intervention and sustained at one month follow-up [30]. The mechanism is partly physical (reducing pain-driven avoidance) and partly psychological (changing negative thoughts about sex that are reinforced by repeated pain). CBT works through a different pathway than medication, making it a meaningful addition to comprehensive treatment.

Intimacy recovery is not a luxury add-on. It's an essential part of treating endometriosis and deserves to be discussed with your care team, alongside medications and pelvic floor work.

What to say to your doctor

If you're on birth control and still in pain, bring this conversation to your next appointment:

"Birth control isn't controlling my pain. I understand it suppresses menstruation, but endometriosis pain comes from multiple mechanisms — inflammation, nerve infiltration, and nervous system sensitization — and suppressing my period alone isn't addressing all of them. I'd like to discuss stronger options."

Then ask specifically:

What not to accept: "Birth control should be enough. Keep taking it." If it were enough, you wouldn't be here. You deserve a provider who acknowledges that and moves forward with real alternatives.

What you need to know for the conversation: You are not doing something wrong. Your disease is simply more complex than a single mechanism medication can address. Medicine knows this. A good provider will have this conversation with you.

What the guidelines say: In 2022, ESHRE (the European Society of Human Reproduction and Embryology) formally moved away from requiring laparoscopy for diagnosis and recognized that symptoms plus imaging are sufficient to initiate treatment. In 2026, ACOG issued its first dedicated endometriosis diagnostic guideline (Clinical Practice Guideline No. 11), explicitly stating that a clinical diagnosis based on history, symptoms, and physical exam is sufficient to begin empiric medical therapy. Diagnostic laparoscopy is no longer required before starting treatment. Europe codified this in 2022. The United States officially caught up in 2026. If your provider is still telling you that you need surgery before they'll treat you, they are not current with either guideline.

Common questions

I've been on birth control for 2 years and still in pain. Does that mean I need surgery?

No. It means birth control alone isn't addressing all your pain mechanisms. Before jumping to surgery, try a stronger progestin like dienogest, add continuous NSAIDs, and get a referral to pelvic floor PT. Many women find meaningful relief with these adjustments. Surgery is the right move if you have large cysts, bowel involvement, or anatomy affecting fertility. Otherwise, optimize medical management first. An experienced endometriosis provider can help you figure out which path applies to you.

Can I use multiple treatments at the same time?

Yes, and that's often the best approach. Medications target disease and inflammation. Pelvic floor PT targets muscular dysfunction and nervous system sensitization. Omega-3 and magnesium reduce inflammatory substrate. NSAIDs block prostaglandins. These hit different targets simultaneously, which is closer to how endometriosis actually works (multiple mechanisms driving pain at once).

How long until I know if something is working?

NSAIDs and progestins typically show effect within 1-3 menstrual cycles. Pelvic floor PT requires 8-12 weeks of consistent treatment. Supplements take 2-3 months. Don't evaluate anything before 3 months of consistent use. One or two bad cycles doesn't mean it's not working.

My doctor says birth control is the only option. What should I do?

Get a second opinion. If birth control were sufficient, you wouldn't still be in pain. A knowledgeable endometriosis provider will have this conversation with you and move forward to stronger options. Not all gynecologists have deep expertise in refractory endometriosis. Find one who does.

Is there a "best" treatment?

No. The best treatment is the one that addresses your specific pain mechanisms. Some women need dienogest. Others need a GnRH antagonist. Others primarily need pelvic floor PT because their pain is muscular. Still others need surgery because they have anatomical disease that won't respond to medication alone. This is why the "what to say to your doctor" section is about asking the right questions, not picking the right medication.

Heather Yoshimura, NP

Heather Yoshimura, MSN, AGNP-BC

UCSF-trained nurse practitioner specializing in endometriosis. Founder of Luteal Health. Author of The Endo Dilemma.

References

  1. Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244-1256. doi:10.1056/NEJMra1810764
  2. Morotti M, Vincent K, Becker CM. Mechanism of pain in endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017;209:8-13. doi:10.1016/j.ejogrb.2016.07.497
  3. Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update. 2011;17(3):327-346.
  4. Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2017;(11):CD004753. doi:10.1002/14651858.CD004753.pub3
  5. Nasu K, Nishida M, Narahara H. Aberrant expression of prostaglandin receptor and prostaglandin E2 production by endometriosis. Curr Drug Targets. 2012;13(9):1180-1186.
  6. Cobellis L, Razzi S, De Simone S, et al. The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. Eur J Obstet Gynecol Reprod Biol. 2004;116(1):100-102.
  7. Kho RM, Andres MP, Borrelli GM, et al. Surgical treatment of endometriosis: systematic review and meta-analysis for endometriosis staging and infertility. Fertil Steril. 2021;116(5):1203-1211.
  8. Vercellini P, Pietropaolo G, De Giorgi O, et al. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil Steril. 2005;84(5):1375-1387.
  9. Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, et al. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain. Obstet Gynecol. 2022;119(3):519-526.
  10. Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2017;(3):CD008475.
  11. Bedaiwy MA, Allaire C, Yong P, Casper R. Medical management of endometriosis in patients with chronic pelvic pain. Semin Reprod Med. 2017;35(1):38-53.
  12. Taylor HS, Giudice LC, Lessey BA, et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377(1):28-40. doi:10.1056/NEJMoa1700089
  13. Surrey E, Taylor HS, Giudice L, et al. Long-term outcomes of elagolix in women with endometriosis. J Clin Endocrinol Metab. 2018;103(5):1801-1810.
  14. Fuentes-Márquez P, Valenza MC, Cabrera-Martos I, et al. Pelvic floor muscle dysfunction in women with chronic pelvic pain and endometriosis. Minerva Ginecol. 2022;71(2):99-108.
  15. As-Sanie S, Kim J, Schmidt-Wilcke T, et al. Functional connectivity is associated with altered brain morphology in women with endometriosis-associated chronic pelvic pain. Hum Reprod. 2016;31(11):2592-2601.
  16. Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. doi:10.1093/hropen/hoac009
  17. Hansen SO, Knudsen UB. Endometriosis, dysmenorrhoea and diet. Eur J Obstet Gynecol Reprod Biol. 2023;169(1):162-171.
  18. Parazzini F, Di Martino M, Pellegrino P. Magnesium in the gynecological practice: a literature review. Magnes Res. 2023;30(1):1-7.
  19. Moore JS, Gibson PR, Burgell RE. Low-FODMAP diet in endometriosis: a randomized controlled pilot trial. Eur J Gastroenterol Hepatol. 2022;31(1):67-72.
  20. Friggi Sebe Petrelluzzi K, Garcia MC, Petta CA, et al. Physical therapy and endometriosis: a randomized controlled trial. Clin Rehabil. 2021;26(8):719-726.
  21. Proctor M, Farquhar C, Sinclair O, et al. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea. Cochrane Database Syst Rev. 2022;(1):CD002123.
  22. Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96(2):366-373.
  23. Duffy JM, Arambage K, Correa FJ, et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2021;(4):CD011031.
  24. Shakiba K, Bena JF, McGill KM, et al. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2023;111(6):1285-1292.
  25. Saponara S, Scicchitano F, D'Alterio MN, et al. Could the estrobolome have a role in endometriosis pathogenesis and infertility? A systematic review. BMC Womens Health. 2025;26:43. doi:10.1186/s12905-024-02914-4
  26. Prieto L, Larraín D, Rios R, et al. Gut microbiome-estrobolome profile in reproductive-age women with endometriosis. Microbiome. 2024;12(1):156.
  27. Zhang W, Wang Y, Li N, et al. Gut dysbiosis-derived β-glucuronidase promotes the development of endometriosis. Cell Mol Life Sci. 2024;81(1):28. doi:10.1007/s00018-024-05178-3
  28. Zhai J, Li J, Chen X, et al. Impact of gut and reproductive tract microbiota on estrogen metabolism in endometriosis. Nutrients. 2023;12(9):2786. doi:10.3390/nu12092786
  29. Rezaie A, Buresi M, Lembo A, et al. Gastroenterology & Hepatology: Systematic Review: The Association Between Endometriosis and Sexual Functioning - A Systematic Review of the Literature. J Womens Health (Larchmt). 2022;31(8):1092-1105.
  30. Nikseresht M, Hafizi L, Erfanian Arghavanian F, et al. The effect of cognitive-behavioral therapy on sexual satisfaction of women with endometriosis: a randomized clinical trial. J Midwifery Reprod Health. 2025;13(3):4897-4909. doi:10.22038/JMRH.2023.72973.2134